Re-evaluation of IL-10 signaling reveals novel insights on the contribution of the intracellular domain of the IL-10R2 chain

PLoS One. 2017 Oct 10;12(10):e0186317. doi: 10.1371/journal.pone.0186317. eCollection 2017.

Abstract

Interleukin-10 (IL-10) is an anti-inflammatory cytokine that plays a key role in maintaining immune homeostasis. IL-10-mediated responses are triggered upon binding to a heterodimeric receptor complex consisting of IL-10 receptor (IL-10R)1 and IL-10R2. Engagement of the IL-10R complex activates the intracellular kinases Jak1 and Tyk2, but the exact roles of IL-10R2 and IL-10R2-associated signaling via Tyk2 remain unclear. To elucidate the contribution of IL-10R2 and its signaling to IL-10 activity, we re-evaluated IL-10-mediated responses on bone marrow-derived dendritic cells, macrophages and mast cells. By using bone marrow from IL-10R-/- mice it was revealed that IL-10-mediated responses depend on both IL-10R1 and IL-10R2 in all three cell types. On the contrary, bone marrow-derived cells from Tyk2-/- mice showed similar responses to IL-10 as wild-type cells, indicating that signaling via this IL-10R2-associated kinase only plays a limited role. Tyk2 was shown to control the amplitude of STAT3 activation and the up-regulation of downstream SOCS3 expression. SOCS3 up-regulation was found to be cell-type dependent and correlated with the lack of early suppression of LPS-induced TNF-α in dendritic cells. Further investigation of the IL-10R complex revealed that both the extracellular and intracellular domains of IL-10R2 influence the conformation of IL-10R1 and that both domains were required for transducing IL-10 signals. This observation highlights a novel role for the intracellular domain of IL-10R2 in the molecular mechanisms of IL-10R activation.

MeSH terms

  • Animals
  • Bone Marrow Cells / cytology
  • Bone Marrow Cells / drug effects
  • Bone Marrow Cells / immunology
  • Cloning, Molecular
  • Dendritic Cells / cytology
  • Dendritic Cells / drug effects
  • Dendritic Cells / immunology*
  • Gene Expression
  • Gene Expression Regulation
  • Interleukin-10 / genetics
  • Interleukin-10 / immunology*
  • Interleukin-10 / pharmacology
  • Lipopolysaccharides / pharmacology
  • Macrophages / cytology
  • Macrophages / drug effects
  • Macrophages / immunology*
  • Mast Cells / cytology
  • Mast Cells / drug effects
  • Mast Cells / immunology*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Nicotiana / genetics
  • Nicotiana / metabolism
  • Organ Specificity
  • Primary Cell Culture
  • Protein Binding
  • Protein Interaction Domains and Motifs
  • Protein Isoforms / deficiency
  • Protein Isoforms / genetics
  • Protein Isoforms / immunology
  • Receptors, Interleukin-10 / deficiency
  • Receptors, Interleukin-10 / genetics
  • Receptors, Interleukin-10 / immunology*
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism
  • STAT3 Transcription Factor / genetics
  • STAT3 Transcription Factor / immunology
  • Signal Transduction / immunology*
  • Suppressor of Cytokine Signaling 3 Protein / genetics
  • Suppressor of Cytokine Signaling 3 Protein / immunology
  • TYK2 Kinase / deficiency
  • TYK2 Kinase / genetics
  • TYK2 Kinase / immunology*
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / immunology

Substances

  • IL10 protein, mouse
  • Lipopolysaccharides
  • Protein Isoforms
  • Receptors, Interleukin-10
  • Recombinant Proteins
  • STAT3 Transcription Factor
  • Socs3 protein, mouse
  • Stat3 protein, mouse
  • Suppressor of Cytokine Signaling 3 Protein
  • Tumor Necrosis Factor-alpha
  • Interleukin-10
  • TYK2 Kinase
  • Tyk2 protein, mouse

Grants and funding

This work was partly funded by Synthon BV, Nijmegen, The Netherlands. There was no additional external funding received for this study.